These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3775862)

  • 1. Aerogenic vaccination of mice with Mycobacterium bovis BCG.
    Orme IM; Collins FM
    Tubercle; 1986 Jun; 67(2):133-40. PubMed ID: 3775862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis.
    Aldwell FE; Cross ML; Fitzpatrick CE; Lambeth MR; de Lisle GW; Buddle BM
    Vaccine; 2006 Mar; 24(12):2071-8. PubMed ID: 16332403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations.
    Sharpe S; White A; Sarfas C; Sibley L; Gleeson F; McIntyre A; Basaraba R; Clark S; Hall G; Rayner E; Williams A; Marsh PD; Dennis M
    Tuberculosis (Edinb); 2016 Dec; 101():174-190. PubMed ID: 27865390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization of mice with Mycobacterium leprae/Mycobacterium bovis BCG admixtures: modulation of the acquired response to BCG.
    Orme IM
    Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):293-8. PubMed ID: 3298475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination of European badgers (Meles meles) with BCG by the subcutaneous and mucosal routes induces protective immunity against endobronchial challenge with Mycobacterium bovis.
    Corner LA; Costello E; Lesellier S; O'Meara D; Gormley E
    Tuberculosis (Edinb); 2008 Nov; 88(6):601-9. PubMed ID: 18468490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
    Mollenkopf HJ; Kursar M; Kaufmann SH
    J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single dose of killed Mycobacterium bovis BCG in a novel class of adjuvant (Novasome) protects guinea pigs from lethal tuberculosis.
    Chambers MA; Wright DC; Brisker J; Williams A; Hatch G; Gavier-Widén D; Hall G; Marsh PD; Glyn Hewinson R
    Vaccine; 2004 Feb; 22(8):1063-71. PubMed ID: 15161084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing the protective efficacy of a BCG homologous prime-boost vaccination regime against tuberculosis.
    Griffin JF; Mackintosh CG; Rodgers CR
    Vaccine; 2006 Feb; 24(6):835-45. PubMed ID: 16098638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination.
    Lin MY; Geluk A; Smith SG; Stewart AL; Friggen AH; Franken KL; Verduyn MJ; van Meijgaarden KE; Voskuil MI; Dockrell HM; Huygen K; Ottenhoff TH; Klein MR
    Infect Immun; 2007 Jul; 75(7):3523-30. PubMed ID: 17502400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
    Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
    J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.
    Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Eum SY; Cho SN; Shin SJ
    PLoS One; 2015; 10(10):e0141577. PubMed ID: 26509812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First data on Eurasian wild boar response to oral immunization with BCG and challenge with a Mycobacterium bovis field strain.
    Ballesteros C; Garrido JM; Vicente J; Romero B; Galindo RC; Minguijón E; Villar M; Martín-Hernando MP; Sevilla I; Juste R; Aranaz A; de la Fuente J; Gortázar C
    Vaccine; 2009 Nov; 27(48):6662-8. PubMed ID: 19747578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cationic liposomes on BCG trafficking and vaccine-induced immune responses following a subcutaneous immunization in mice.
    Derrick SC; Yang A; Parra M; Kolibab K; Morris SL
    Vaccine; 2015 Jan; 33(1):126-32. PubMed ID: 25448108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice.
    Giri PK; Verma I; Khuller GK
    J Infect; 2006 Nov; 53(5):350-6. PubMed ID: 16442629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attrition of T-cell functions and simultaneous upregulation of inhibitory markers correspond with the waning of BCG-induced protection against tuberculosis in mice.
    Nandakumar S; Kannanganat S; Posey JE; Amara RR; Sable SB
    PLoS One; 2014; 9(11):e113951. PubMed ID: 25419982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraduodenal vaccination of brushtail possums with bacille Calmette-Guérin enhances immune responses and protection against Mycobacterium bovis infection.
    Buddle BM; Aldwell FE; Keen DL; Parlane NA; Yates G; de Lisle GW
    Int J Tuberc Lung Dis; 1997 Aug; 1(4):377-83. PubMed ID: 9432396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph node targeting of BCG vaccines amplifies CD4 and CD8 T-cell responses and protection against Mycobacterium tuberculosis.
    Waeckerle-Men Y; Bruffaerts N; Liang Y; Jurion F; Sander P; Kündig TM; Huygen K; Johansen P
    Vaccine; 2013 Feb; 31(7):1057-64. PubMed ID: 23273509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological responses of Eurasian badgers (Meles meles) vaccinated with Mycobacterium bovis BCG (bacillus calmette guerin).
    Southey A; Sleeman DP; Lloyd K; Dalley D; Chambers MA; Hewinson RG; Gormley E
    Vet Immunol Immunopathol; 2001 May; 79(3-4):197-207. PubMed ID: 11389955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against an aerogenic Mycobacterium tuberculosis infection in BCG-immunized and DNA-vaccinated mice is associated with early type I cytokine responses.
    Goter-Robinson C; Derrick SC; Yang AL; Jeon BY; Morris SL
    Vaccine; 2006 Apr; 24(17):3522-9. PubMed ID: 16519971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.